Journal of Muscle Research & Cell Motility

, Volume 20, Issue 7, pp 605–625 | Cite as

Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse

  • J. M. Gillis


Functional Consequence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allard B and Rougier O (1997) Similarity of ATP-dependent K+ channels in skeletal muscle fibres from normal and mutant mdx mice. J Physiol 498: 319–325.Google Scholar
  2. Anagli J, Hagmann J and Shaw E (1993) Affinity labelling of the Ca2+-activated neutral proteinase (calpain) in intact human platelets. Biochem J 289 (Pt 1): 93–99.Google Scholar
  3. Anderson JE, Liu L and Kardami E (1991) Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. Dev Biol 147: 96–109.Google Scholar
  4. Anderson JE, Liu L and Kardami E (1994) The effects of hyperthyroidism on muscular dystrophy in the mdx mouse: greater dystrophy in cardiac and soleus muscle. Muscle Nerve 17: 64–73.Google Scholar
  5. Baki A, Tompa P, Alexa A, Molnár O and Friedrich P (1996) Autolysis parallels activation of µl-calpain. Biochem J 318: 897–901.Google Scholar
  6. Bakker AJ, Head SI, Williams DA and Stephenson DG (1993) Ca2+levels in myotubes grown from skeletal muscle of dystrophic (mdx) and normal mice. J Physiol 460: 2–13.Google Scholar
  7. Baumbach LL, Chamberlain JS, Ward PA, Farwell NJ and Caskey CT (1989) Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology 39: 465–474.Google Scholar
  8. Blake DJ, Tinsley JM and Davies KE (1996) Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 6: 37–47.Google Scholar
  9. Bodensteiner JB and Engel AG (1978) Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibres in 114 biopsies. Neurology 28: 439–446.Google Scholar
  10. Boland B, Himpens B, Casteels R and Gillis JM (1993) Lack of dystrophin but normal calcium homeostasis in the smooth muscle from dystrophic mdx mice. J Muscle Res Cell Motil 14: 133–139.Google Scholar
  11. Boland B, Himpens B, Denef JF and Gillis JM (1995) Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse. Muscle Nerve 18: 649–657.Google Scholar
  12. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC and Bredt DS (1996a) Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84: 757–767.Google Scholar
  13. Brenman JE, Chao DS, Xia H, Adalpe K and Bredt DS (1996b) Interaction of nitric oxide synthase complexed with dystrophin and absent from sarcolemma in Duchenne muscular dystrophy. Cell 82: 743–752.Google Scholar
  14. Brocks L, Wirtz P, Loermans H and Binkhorst R (1992) Effects of early immobilization on the functional capacity of dystrophic (ReJ 129 dy/dy) mouse leg muscles. Int J Exp Pathol 73: 223–229.Google Scholar
  15. Brooks SV (1998) Rapid recovery following contraction-induced injury to in situ skeletal muscles in mdx mice. J Muscle Res Cell Motil 19: 179–187.Google Scholar
  16. Bulfield G, Siller WG, Wight PAL and Moore KJ (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189–1192.Google Scholar
  17. Carlson CG (1996) Acetylcholine receptor and calcium leakage activity in nondystrophic and dystrophic myotubes (MDX). Muscle Nerve 19: 1258–1267.Google Scholar
  18. Carlson CG (1998) The dystrophinopathies: an alternative to the structural hypothesis. Neurobiol Dis 5: 3–15.Google Scholar
  19. Carlson CG (1999) Spontaneous changes in acetylcholine receptor and calcium leakage activity in cell-attached patches from cultured dystrophic myotubes. Pflügers Arch/Eur J Physiol 437: 371–380.Google Scholar
  20. Carlson CG and Makiejus RV(1990) Anoninvasive procedure to detect muscle weakness in the mdx mouse. Muscle Nerve 13: 480–484.Google Scholar
  21. Carlson CG and Officer T (1996) Single channel evidence for a cytoskeletal defect involving acetylcholine receptors and calcium influx in cultured dystrophic (mdx) myotubes. Muscle Nerve 19: 1116–1126.Google Scholar
  22. Carnwath JW and Shotton DM (1987) Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 80: 39–54.Google Scholar
  23. Carpenter JL, Hoffman EP, Romanul FC, Kunkel LM, Rosales RK, Ma NS, Dasbach JJ, Rae JF, Moore FM, and McAfee MB et al. (1989) Feline muscular dystrophy with dystrophin deficiency. Am J Pathol 135: 909–919.Google Scholar
  24. Carter GT, Kikuchi N, Abresch RT, Walsh SA, Horasek SJ and Fowler WM Jr. (1994) Effects of exhaustive concentric and eccentric exercise on murine skeletal muscle. Arch Phys Med Rehabil 75: 555–559.Google Scholar
  25. Carter GT, Wineinger MA, Walsh SA, Horasek SJ, Abresch RT and Fowler WM Jr. (1995) Effect of voluntary wheel-running exercise on muscles of the mdx mouse. Neuromuscul Disord 5: 323–332.Google Scholar
  26. Cavagna GA and Margaria R (1966) Mechanics of walking. J Appl Physiol 21: 271–278.Google Scholar
  27. Chang WJ, Iannaccone ST, Lau KS, Masters BS, McCabe TJ, McMillan K, Padre RC, Spencer MJ, Tidball JG and Stull JT (1996) Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 93: 9142–9147.Google Scholar
  28. Chao DS, Rafael J, Gorospe M, Brenman JE, Rafael JA, Peters MF, Froehner SC, Hoffman EP, Chamberlain JS and Bredt DS (1996) Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med 184: 609–618.Google Scholar
  29. Chen BM and Grinnell AD (1995) Integrins and modulation of transmitter release from motor nerve terminals by stretch. Science 269: 1578–1580.Google Scholar
  30. Clarke MSF, Khakee R and McNeil PL (1993) Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J Cell Sci 106: 121–133.Google Scholar
  31. Collet C, Allard B, Tourneur Y, Rougier O and Jacquemond V (1999) Indo-1 calcium signals in skeletal musclr fibers from normal and mdx mice. Biophys J 76: A298.Google Scholar
  32. Coulton GR, Curtin N, Morgan JE and Partridge TA (1988a) The mdx mouse skeletal muscle myopathy. II contractile properties. Neuropathol Appl Neurobiol 14: 299–314.Google Scholar
  33. Coulton GR, Morgan JE, Partridge TA and Sloper JC (1988b) The mdx mouse skeletal muscle myopathy: I a histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 14: 53–70.Google Scholar
  34. Crosbie RH, Heighway J, Venzke DP, Lee JC and Campbell KP (1997) Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 272: 31221–31224.Google Scholar
  35. Crosbie RH, Straub V, Yun HY, Lee JC, Rafael JA, Chamberlain JS, Dawson VL, Dawson TM and Campbell KP (1998a) mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet 7: 823–829.Google Scholar
  36. Crosbie RH, Yamada H, Venzke DP, Lisanti MP and Campbell KP (1998b) Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Lett 427: 279–282.Google Scholar
  37. Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR and Campbell KP (1999) Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145: 153–165.Google Scholar
  38. Culligan KG, Mackey AJ, Finn DM, Maguire PB and Ohlendieck K (1998) Role of dystrophin isoforms and associated proteins in muscular dystrophy (Review). Int J Mol Med 2: 639–648.Google Scholar
  39. Davison MD and Critchley DR (1988) Actinins and the DMD protein contain spectrin-like repeats. Cell 52: 159–160.Google Scholar
  40. Deconinck N (1998) Functional evaluation of gene therapy in a mouse model of Duchenne muscular dystrophy. Ph.D.thesis, University of Louvain, Belgium.Google Scholar
  41. Deconinck AE, Potter AC, Tinsley JM, Wood SJ, Vater R, Young C, Metzinger L, Vincent A, Slater CR and Davies KE (1997a) Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 136: 883–894.Google Scholar
  42. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM and Davies KE (1997b) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90: 717–727.Google Scholar
  43. Deconinck N, Ragot T, Maréchal G, Pérricaudet M and Gillis JM (1996) Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc Natl Acad Sci USA 93: 3570–3574.Google Scholar
  44. Deconinck N, Tinsley J, De Backer F, Fisher R, Kahn D, Phelps S, Davies K and Gillis JM (1997c) Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med 3: 1216–1221.Google Scholar
  45. Deconinck N, Rafael JA, Beckers-Bleukx G, Kahn D, Deconinck AE, Davies KE and Gillis JM (1998) Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of limb and respiratory muscles of the mouse. Neuromuscul Disord 8: 362–370.Google Scholar
  46. De Luca A, Pierno S, Camerino C, Huxtable RJ and Camerino DC (1998) Effect of taurine on excitation-contraction coupling of extensor digitorum longus muscle of dystrophic mdx mouse. Adv Exp Med Biol 442: 115–119.Google Scholar
  47. Denetclaw WF, Hopf FW, Cox GA, Chamberlain JS and Steinhardt RA (1994) Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation. Mol Biol Cell 5: 1159–1167.Google Scholar
  48. DiMario JX, Uzman A and Strohman RC (1991) Fiber regeneration is not persitent in dystrophic (MDX) mouse skeletal muscle. Dev Biol 148: 314–321.Google Scholar
  49. Dourdin N, Brustis JJ, Balcerzak D, Elamrani N, Poussard S, Cottin P and Ducastaing A (1997) Myoblast fusion requires fibronectin degradation by exteriorized m-calpain. Exp Cell Res 235: 385–394.Google Scholar
  50. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R and Campbell KP (1998) Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 142: 1461–1471.Google Scholar
  51. Duggan DJ, Gorospe JR, Fanin M, Hoffman EP and Angelini C (1997) Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med 336: 618–624.Google Scholar
  52. Duncan CJ (1978) Role of intracellular calcium in promoting muscle damage: a strategy for controlling the dystrophic condition. Experientia 34: 1531–1535.Google Scholar
  53. Dunn JF and Radda GK (1991) Total ion content of skeletal and cardiac muscle in mdx mouse dystrophy: Ca2+ is elevated at all ages. J Neurol Sci 103: 1105–1110.Google Scholar
  54. Dunn JF, Tracey I and Radda GK (1992) A 31P-NMR study of muscle exercice metabolism in mdx mice: evidence for abnormal pH regulation. J Neurol Sci 113: 108–113.Google Scholar
  55. Engel AG, Yamamoto M and Fishbeck KH (1994) Dystrophinopathies. In: Engel AG and Franzini-Armstrong C (eds) Myology: Basic and Clinical (pp 1133–1197) McGraw-Hill, New York.Google Scholar
  56. England SB, Nicholson LV, Johnson MA, Forrest SM, Love DR, Zubrzycka-Gaarn EE, Bulman DE, Harris JB and Davies KE (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature 343: 180–182.Google Scholar
  57. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG and Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345: 315–319.Google Scholar
  58. Ettinger AJ, Feng G and Sanes JR (1997) Epsilon-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 272: 32534–32538.Google Scholar
  59. Even PC, Decrouy A and Chinet A (1994) Defective regulation of energy metabolism in mdx mouse skeletal muscles. Biochem J 304: 649–654.Google Scholar
  60. Fabbrizio E, Bonet-Kerrache A, Limas F, Hugon G and Mornet D (1995) Dystrophin, the protein that promotes membrane resistance. Biochem Biophys Res Commun 213: 295–301.Google Scholar
  61. Fardeau M, Tomé FMS, Collin H, Augier N, Pons F, Léger J and Léger JJ (1990) Pré sence d'une proté ine de type dystrophine au niveau de la jonction neuromusculaire dans la dystrophie musculaire de Duchenne et la souris mutante ‘mdx’. C R Acad Sci Paris 311: 197–204.Google Scholar
  62. Fenichel GM, Florence JM, Pestronck A, Mendell JR, Moxley RC, Griggs RC, Brooke MH, Miller JP, Robinson J and King W (1991) Long term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology 41: 1874–1877.Google Scholar
  63. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA and Michel T (1998) Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate. J Biol Chem 273: 30249–30254.Google Scholar
  64. Fong P, Turner PR, Denetclaw WF and Steinhardt RA (1990) Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250: 673–676.Google Scholar
  65. Foster AH and Carlson BM (1980) Myotoxicity of local anesthetics and regeneration of the damaged muscle fibers. Anesthes Analg 59: 727–736.Google Scholar
  66. Foxley A, Edwards RHT and Jackson MJ (1991) Enhanced lipid peroxidation in Duchenne muscular dystrophy may be secondary to muscle damage. Biochem Soc Trans 19: 180S.Google Scholar
  67. Franco A and Lansman JB (1990) Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344: 670–673.Google Scholar
  68. Friedrich O, Ehmer T and Fink R (1999) Calcium currents during contraction and shortening in enzymatically isolated murine skeletal muscle fibres. J Physiol 517: 757–770.Google Scholar
  69. Gailly P, Boland B, Himpens B, Casteels R and Gillis JM (1993a) Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium 14: 473–483.Google Scholar
  70. Gailly P, Hermans E, Octave JN and Gillis JM (1993b) Specific increase of genetic expression of parvalbumin in fast skeletal muscle of mdx mice. FEBS Lett 326: 272–274.Google Scholar
  71. Gailly P, Hermans E and Gillis JM (1996) Role of [Ca2+]i in ‘Ca2+stores depletion – Ca2+ entry coupling’ in fibroblast expressing the rat neurotensin receptor. J Physiol 491: 625–636.Google Scholar
  72. Gaschen FP, Hoffman EP, Gorospe JR, Uhl EW, Senior DF, Cardinet GH and Pearce LK (1992) Dystrophin deficiency causes lethal muscle hypertrophy in cats. J Neurol Sci 110: 149–159.Google Scholar
  73. Gillis JM (1996a) The mdx mouse: why diaphragm? Muscle Nerve 19: 1230.Google Scholar
  74. Gillis JM (1996b) Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol Scand 156: 397–406.Google Scholar
  75. Gossrau R (1998) Nitric oxide synthase I (NOS I) is a costameric enzyme in rat skeletal muscle. Acta Histochem 100: 451–462.Google Scholar
  76. Goudemant JF, Deconinck N, Tinsley JM, Robert A, Davies K and Gillis JM (1998) Expression of truncated utrophin improves pH recovery in exercising muscles of dystrophic mdx mice. A 31P NMR study. Neuromuscul Disord 8: 371–379.Google Scholar
  77. Grady RM, Merlie JP and Sanes JR (1997) Subtle neuromuscular defects in utrophin-deficient mice. J Cell Biol 136: 871–882.Google Scholar
  78. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS and Sanes JR (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90: 729–738.Google Scholar
  79. Hack AA, Ly CT, Jiang F, Clendenin CJ, Sigrist KS, Wollmann RL and McNally EM (1998) Gamma-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142: 1279–1287.Google Scholar
  80. Hall-Craggs EC (1974) Rapid degeneration and regeneration of a whole skeletal muscle following treatment with bupivacaine (Marcain). Exp Neurol 43: 349–358.Google Scholar
  81. Hassoni H, Brown AE and Harris JB (1996) Calcium and Duchenne muscular dystrophy. J Physiol 491: 129P.Google Scholar
  82. Haws CM and Lansman JB (1991) Developmental regulation of mechanosensitive calcium channels in skeletal muscle from normal and mdx mice. Proc Roy Soc Lond B 245: 173–177.Google Scholar
  83. Head SI (1993) Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. J Physiol 469: 11–19.Google Scholar
  84. Hocherman SD and Bezanilla F (1996) A patch-clamp study of delayed rectifier currents in skeletal muscle of control and mdx mice. J Physiol 493: 113–128.Google Scholar
  85. Hoffman EP, Brown RH and Kunkel LM (1987a) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919–928.Google Scholar
  86. Hoffman EP, Knudson CM, Campbell KP and Kunkel LM (1987b) Subcellular fractionation of dystrophin to the triads of skeletal muscle. Nature 330: 754–758.Google Scholar
  87. Hollingworth S, Marshall MW and Robson E (1990) Excitation contraction coupling in normal and mdx mice. Muscle Nerve 13: 16–20.Google Scholar
  88. Hopf FW, Turner PR, Denetclaw WF, Reddy P and Steinhardt RA (1996) A critical evaluation of resting intracellular free calcium regulation in dystrophic mdx muscle. Am J Physiol 271: C1325–C1339.Google Scholar
  89. Hutter OF, Burton FL and Bovell DL (1991) Mechanical properties of normal and mdx sarcolemma: bearing on function of dystrophin. J Muscle Res Cell Motil 12: 585–589.Google Scholar
  90. Imbert N, Cognard C, Duport G, Guillou C and Raymond G (1995) Abnormal calcium homeostasis in Duchenne muscular dystrophy myotubes contracting in vitro. Cell Calcium 18: 177–186.Google Scholar
  91. Imbert N, Vandebrouck C, Constantin B, Duport G, Guillou C, Cognard C and Raymond G (1996) Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromusc Disord 6: 351–360.Google Scholar
  92. Ingber DE (1993) Cellular tensegrity: defining new rules of biological design that govern the cytoskeleton. J Cell Sci 104: 613–627.Google Scholar
  93. Ingber DE (1997) Tensegrity: the architectural basis of cellular mechanotransduction. Ann Rev Physiol 59: 575–599.Google Scholar
  94. Ingber DE, Dike L, Hansen L, Karp S, Liley H, Maniotis A, McNamee H, Mooney D, Plopper G and Sims J et al. (1994) Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol 150: 173–224.Google Scholar
  95. Isaacs ER, Bradley WG and Henderson G (1973) Longitudinal fibre splitting in muscular dystrophy: a serial cinematographic study. J Neurol Neurosurg Psychiatry 36: 813–819.Google Scholar
  96. James M, Nguyen TM, Wise CJ, Jones GE and Morris GE (1996) Utrophin-dystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton 33: 163–174.Google Scholar
  97. Jasmin BJ, Alameddine H, Lunde JA, Stetzkowski-Marden F, Collin H, Tinsley JM, Davies KE, Tomé FM, Parry DJ and Cartaud J (1995) Expression of utrophin and its mRNA in denervated mdx mouse muscle. FEBS Lett 374: 393–398.Google Scholar
  98. Jockusch H, Friedrich G and Zippel M (1990) Serum parvalbumin, an indicator of muscle disease in murine dystrophy and myotonia. Muscle Nerve 13: 551–555.Google Scholar
  99. Kämper A and Rodemann HP (1992) Alterations of protein degradation and 2-D protein pattern in muscle cells of MDX and DMD origin. Biochem Biophys Res Commun 189: 1484–1490.Google Scholar
  100. Kampfl A, Posmantur R, Nixon R, Grynspan F, Zhao X, Liu SJ, Newcomb JK, Clifton GL and Hayes RL (1996) mu-calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J Neurochem 67: 1575–1583.Google Scholar
  101. Kapprell HP and Goll DE (1989) Effect of Ca2+ on binding of the calpains to calpastatin. J Biol Chem 264: 17888–17896.Google Scholar
  102. Kargacin ME and Kargacin GJ (1996) The sarcoplasmic reticulum calcium pump is functionally altered in dystrophic muscles. Biochim Biophys Acta 1290: 4–8.Google Scholar
  103. Karpati G and Carpenter S (1986) Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am J Med Genet 25: 653–658.Google Scholar
  104. Karpati G, Carpenter S and Prescott S (1988) Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11: 795–803.Google Scholar
  105. Karpati G, Zubrzycka-Gaarn EE, Carpenter S, Bulman DE, Ray PN and Worton RG (1990) Age-related conversion of dystrophin-negative to-positive fiber segments of skeletal but not cardiac muscle fibers in heterozygote mdx mice. J Neuropathol Exp Neurol 49: 96–105.Google Scholar
  106. Kelly AM (1978) Sattelite cells and myofiber growth in the rat soleus and extensor digitorum longus muscles. Dev Biol 65: 1–10.Google Scholar
  107. Khurana TS, Hoffman EP and Kunkel LM (1990) Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem 265: 16717–16720.Google Scholar
  108. Khurana TS, Watkins SC, Chafey P, Chelly J, Tomé FM, Fardeau M, Kaplan JC and Kunkel LM (1991) Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord 1: 185–194.Google Scholar
  109. Khurana TS, Prendergast RA, Alameddine HS, Tomé FM, Fardeau M, Arahata K, Sugita H and Kunkel LM (1995) Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 182: 467–475.Google Scholar
  110. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP and Kunkel LM (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50: 509–517.Google Scholar
  111. Kometani K, Tsugeno H and Yamada K (1990) Mechanical and energetic properties of dystrophic (mdx) mouse muscle. Jpn J Physiol 40: 541–549.Google Scholar
  112. Kramer R, Lochmuller H, Abicht A, Rudel R and Brinkmeier H (1998) Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice. Neuromuscul Disord 8: 542–550.Google Scholar
  113. Kunkel LM and Hoffman EP (1989) Duchenne/Becker muscular dystrophy: a short overview of the gene, the protein, and current diagnostics. Br Med Bull 45: 630–643.Google Scholar
  114. Kuznetsov AV, Winkler K, Wiedemann FR, von Bossanyi P, Dietzmann K and Kunz WS (1998) Impaired mitochondrial oxidative phosphorylation in skeletal muscle of the dystrophin-deficient mdx mouse. Mol Cell Biochem 183: 87–96.Google Scholar
  115. Law DJ, Allen DL and Tidball JG (1994) Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci 107: 1477–1483.Google Scholar
  116. Law DJ, Caputo A and Tidball JG (1995) Site and mechanics of failure in normal and dystrophin-deficient skeletal muscle. Muscle Nerve 18: 216–223.Google Scholar
  117. Law DJ and Tidball JG (1993) Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle. Am J Pathol 142: 1513–1523.Google Scholar
  118. Leberer E, Hartner KT and Pette D (1988) Postnatal development of Ca2+ sequestration by the sarcoplasmic reticulum of fast and slow muscles in normal and dystrophic mice. Eur J Biochem 174: 247–253.Google Scholar
  119. Leijendekker WJ, Passaquin AC, Metzinger L and Rüegg UT (1996) Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress. Br J Pharmacol 118: 611–616.Google Scholar
  120. Liberona JL, Powell JA, Shenoi S, Petherbridge L, Caviedes R and Jaimovich E (1998) Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines. Muscle Nerve 21: 902–909.Google Scholar
  121. Lucas-Heron B (1996) Absence of a calmitine-specific protease inhibitor in skeletal muscle mitochondria of patients with Duchenne's muscular dystrophy. Biochem Biophys Res Commun 225: 701–704.Google Scholar
  122. Lucas-Heron B, Schmitt N and Ollivier B (1990a) Calmitine: a calcium-binding mitochondrial protein specific for fast-twitch muscle fibers. Neurosci Lett 115: 103–107.Google Scholar
  123. Lucas-Heron B, Schmitt N and Ollivier B (1990b) Muscular dystrophy: possible role of mitochondrial deficiency in muscle degeneration processes. J Neurol Sci 95: 327–334.Google Scholar
  124. Lucas-Heron B, Schmitt N and Ollivier B (1994) Mdx mouse skeletal muscle: could a mitochondrial factor be responsible for the absence of progressive necrosis? Neurosci Lett 169: 97–100.Google Scholar
  125. Lyons PR and Slater CR (1991) Structure and function of the neuromuscular junction in young adult mdx mice. J Neurocytol 20: 969–981.Google Scholar
  126. MacLennan PA and Edwards RHT (1990) Protein turnover is elevated in muscles of mdx mice in vivo. Biochem J 268: 795–797.Google Scholar
  127. MacLennan PA, McArdle A and Edwards RH (1991) Effects of calcium on protein turnover of incubated muscles from mdx mice. Am J Physiol 260: E594–E598.Google Scholar
  128. Maréchal G and Beckers-Bleukx G (1988) Force-velocity and myosin isozymes in muscles of dystrophic (mdx) mice. Arch Int Physiol Biochim 96: P16.Google Scholar
  129. Mathes C, Bezanilla F and Weiss RE (1991) Sodium current and membrane potential in EDL muscle fibers from normal and dystrophic (mdx) mice. Am J Physiol 261: C718–C725.Google Scholar
  130. Matsubara I, Goldman YE and Simmons RM (1984) Changes in the lateral filament spacing of skinned muscle fibres when cross-bridges attach. J Mol Biol 173: 15–33.Google Scholar
  131. Matsuda R, Nishikawa A and Tanaka H (1995) Visualization of dystrophic muscle fibres in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Biochem 118: 959–964.Google Scholar
  132. Matsumura K and Campbell KP (1994) Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17: 2–15.Google Scholar
  133. Matsumura K, Ervasti J, Ohlendieck K, Kahl S and Campbell K (1993) Association of dystrophin-related protein with dystrophin associated proteins in mdx mouse muscle. Nature 360: 588–591.Google Scholar
  134. McArdle A and Jackson MJ (1996) Heat shock protein 70 expression in skeletal muscle. Biochem Soc Trans 24: 485S.Google Scholar
  135. McArdle A, Edwards RHT and Jackson MJ (1991) Effects of the contractile activity on muscle damage in the dystrophin-deficient mdx mice. Clin Sci 80: 367–371.Google Scholar
  136. McArdle A, Edwards RHT and Jackson MJ (1992) Accumulation of calcium by normal and dystrophin-deficient mouse muscle during contractile activity in vitro Clin Sci 82: 455–459.Google Scholar
  137. McArdle A, Edwards RHT and Jackson MJ (1994) Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17: 1378–1384.Google Scholar
  138. McArdle A, Helliwell TR, Beckett GJ, Catapano M, Davis A and Jackson MJ (1998) Effect of propylthiouracil-induced hypothyroidism on the onset of skeletal muscle necrosis in dystrophin-deficient mdx mice. Clinical Sciences 95: 83–89.Google Scholar
  139. McCarter GC, Denetclaw WF, Reddy P and Steinhardt RA (1997) Lipofection of a cDNA plasmid containing the dystrophin gene lowers intracellular free calcium and calcium leak channel activity in mdx myotubes. Gene Ther 4: 483–487.Google Scholar
  140. Menke A and Jockusch H (1991) Decreased osmotic stability of dystrophinless muscle cells from the mdx mouse. Nature 349: 69–71.Google Scholar
  141. Metzinger L, Blake DJ, Squier MV, anderson LV, Deconinck AE, Nawrotzki R, Hilton-Jones D and Davies KE (1997) Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet 6: 1185–1191.Google Scholar
  142. Mizumo Y (1992) Prevention of myonecrosis in mdx mice: effect of immobilization by the local tetanus method. Brain Dev 14: 319–322.Google Scholar
  143. Mizumo Y, Nonaka I, Hirai S and Ozawa E (1993) Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD carriers and control subjects. J Neurol Sci 119: 43–52.Google Scholar
  144. Moens P, Baatsen PHWW and Maréchal G (1993) Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14: 446–451.Google Scholar
  145. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H and Kunkel LM (1988) An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 2: 90–95.Google Scholar
  146. Mongini T, Ghigo D, Doriguzzi C, Bussolino F, Pescarmona G, Pollo B, Schiffer D and Bosia A(1988) Free cytoplasmic Ca+ + at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients. Neurology 38: 476–480.Google Scholar
  147. Nagel A, Lehmann-Horn F and Engel AG (1990) Neuromuscular transmission in the mdx mouse. Muscle Nerve 13: 742–749.Google Scholar
  148. Ohlendieck K and Campbell KP (1991a) Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115: 1685–1694.Google Scholar
  149. Ohlendieck K and Campbell KP (1991b) Dystrophyn constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett 283: 230–234.Google Scholar
  150. Pardo JV, Siliciano JD and Craig SW (1983) A vinculin-containing cortical lattice in skeletal muscle: transverse lattice elements (costameres) mark sites of attachment between myofibrils and sarcolemma. Proc Natl Acad Sci USA 80: 1008–1012.Google Scholar
  151. Pasternack C, Wong S and Elson EL (1995) Mechanical function of dystrophin in muscle cells. J Cell Biol 128: 355–361.Google Scholar
  152. Pastoret C and Sebille A (1995) mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129: 95–107.Google Scholar
  153. Péréon Y, Khammari A and Noireaud J (1996) Perchlorate differentially potentiates excitation-contraction coupling of diaphragm muscle from mdx and control mice. Acta Physiol Scand 158: 287–294.Google Scholar
  154. Pete D and Vrbova G (1992) Adaptation of mamalian skeletal muscle fibers to chronic electrical stimulation. Rev Physiol Biochem Pharmacol 120: 116–202.Google Scholar
  155. Petrof BJ, Shrager JB, Stedman HH, Kelly AM and Sweeney HL (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710–3714.Google Scholar
  156. Poussard S, Cottin P, Brustis JJ, Talmat S, Elamrani N and Ducastaing A (1993) Quantitative measurement of calpain I and II mRNAs in differentiating rat muscle cells using a competitive polymerase chain reaction method. Biochimie 75: 885–890.Google Scholar
  157. Pressmar J, Brinkmeier H, Seewald MJ, Naumann T and Rü del R (1994) Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres. Pflügers Arch 426: 499–505.Google Scholar
  158. Pulido SM, Passaquin AC, Leijendekker WJ, Challet C, Wallimann T and Rüegg UT (1998) Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett 439: 357–362.Google Scholar
  159. Putney JW Jr (1990) Capacitative calcium entry revisited. Cell Calcium 11: 611–624.Google Scholar
  160. Quinlan JG, Johnson SR and Samaha FJ (1990) Dantrolene normalizes serum creatine kinase in MDX mice [letter]. Muscle Nerve 13: 268–269.Google Scholar
  161. Reeve JL, McArdle A and Jackson MJ (1997) Age-related changes in muscle calcium content in dystrophin-deficient mdx muscle. Muscle Nerve 20: 357–360.Google Scholar
  162. Remmers JE (1976) Analysis of ventilatory responses. Chest 70 (suppl.): 134–137.Google Scholar
  163. Rivet-Bastide M, Imbert N, Cognard C, Duport G, Rideau Y and Raymond G (1993) Changes in cytosolic resting ionized calcium level and in calcium transients during in vitro development of normal and Duchenne muscular dystrophy cultured skeletal muscle measured by laser cytofluorimetry using Indo-1. Cell Calcium 14: 563–571.Google Scholar
  164. Rizzuto R, Simpson AW, Brini M and Pozzan T (1992) Rapid changes of mitochondrial Ca2+ revealed by specifically targeted recombinant aequorin. Nature 358: 325–327.Google Scholar
  165. Rosenblatt JD and Woods RI (1992) Hypertrophy of rat extensor digitorum longus muscle injected with bupivacaine. A sequential histochemical, immunohistochemical, histological and morphometric study. J Anat 181: 11–27.Google Scholar
  166. Rybakova IN, Amann KJ and Ervasti JM (1996) A new model for the interaction of dystrophin with F-actin. J Cell Biol 135: 661–672.Google Scholar
  167. Rybakova IN and Ervasti JM (1997) Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through a lateral association. J Biol Chem 272: 28771–28778.Google Scholar
  168. Sacco P, Jones DA, Dick JRT and Vrbova G (1992) Contractile properties and susceptibility to exercise-induced damage of normal and mdx mouse tibialis anterior muscle. Clin Sci 82: 227–236.Google Scholar
  169. Sandri M, Podhorska-Okolov M, Geromel V, Rizzi C, Arslan P, Franceschi C and Carraro U (1997) Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 56: 45–57.Google Scholar
  170. Sandri M, Minetti C, Pedemonte M and Carraro U (1998) Apoptotic myonuclei in human Duchenne muscular dystrophy. Lab Invest 78: 1005–1016.Google Scholar
  171. Sano M, Wada Y, Ii K, Kominami E, Katunuma N and Tsukagoshi H (1988) Immunolocalization of cathepsins B, H and L in skeletal muscle of X-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl) 75: 217–225.Google Scholar
  172. Sawada H, Tsuji S, Kusumoto S, Doi Y and Matsuhita H (1986) Preclinical increase in activity of muscle microsomal trypsin-like protease in murine muscular dystrophy, C57BL/10-mdx. FEBS Lett 199: 193–197.Google Scholar
  173. Schollmeyer JE (1986) Role of Ca2+ and Ca2+-activated protease in myoblast fusion. Exp Cell Res 162: 411–422.Google Scholar
  174. Schotland DL, Bonilla E and Van Meter M (1977) Duchenne dystrophy: alteration in muscle plasma membrane structure. Science 196: 1005–1007.Google Scholar
  175. Sicinski P, Geng Y, Ryder-Cook AS, Barnard EA, Darlison MG and Barnard BJ (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244: 1578–1580.Google Scholar
  176. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS and Lisanti MP (1996) Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J BiolChem 271: 15160–15165.Google Scholar
  177. Spencer MJ and Tidball JG (1992) Calpain concentration is elevated althought net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle. Exp Cell Res 203: 107–114.Google Scholar
  178. Spencer MJ and Tidball JG (1996) Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp Cell Res 226: 264–272.Google Scholar
  179. Spencer MJ, Croall DE and Tidball JG (1995) Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem 270: 10909–10914.Google Scholar
  180. Spencer MJ, Walsh CM, Dorshkind KA, Rodriguez R and Tidball JG (1997) Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest 99: 2745–2751.Google Scholar
  181. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panetteri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT and Kelly AM (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536–539.Google Scholar
  182. Straub V, Bittner RE, Léger JJ and Voit T (1992) Direct visualization of the dystrophin network on skeletal muscle fiber membrane. J Cell Biol 119: 1183–1191.Google Scholar
  183. Street SF (1983) Lateral transmission of tension in frog myofibers: a myofibrillar network and transverse cytoskeletal connections are possible transmitters. J Cell Physiol 114: 346–364.Google Scholar
  184. Sunada Y and Campbell K (1995) Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. Curr Opin Neurol 8: 379–384.Google Scholar
  185. Takagi A, Kojima S, Ida M and Araki M (1992) Increased leakage of calcium ion from the sarcoplasmic reticulum of the mdx mouse. J Neurol Sci 110: 160–164.Google Scholar
  186. Takemitsu M, Ishiura S, Koga R, Kamakura K, Arahata K, Nonaka T and Sugita H (1991) Dystrophin-related protein in the fetal and denervated skeletal muscles of normal and mdx mouse. Biochem Biophys Res Comm 180: 1179–1186.Google Scholar
  187. Talbot JA and Morgan DL (1998) The effects of stretch parameters on eccentric exercise-induced damage to toad skeletal muscle. J Muscle Res Cell Motil 19: 237–245.Google Scholar
  188. Tidball JG (1991) Force transmission across muscle cell membranes. J Biomech 24 (suppl.1): 43–52.Google Scholar
  189. Tidball JG and Law DJ (1991) Dystrophin is required for normal thin filament-membrane associations at myotendinous junctions. Am J Pathol 138: 17–21.Google Scholar
  190. Tidball JG, Albrecht DE, Lokensgard BE and Spencer MJ (1995) Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 108: 2197–2204.Google Scholar
  191. Tinsley JM, Blake DJ, Roche A, Fairbrother U, Riss J, Byth BC, Knight AE, Kendrick-Jones J, Suthers GK, Love DR, Edwards YH and Davies KE (1992) Primary structure of dystrophin-related protein. Nature 360: 591–602.Google Scholar
  192. Tinsley JM and Davies KE (1993) Utrophin: a potential replacement for dystrophin? Neuromusc Disord 3: 537–539.Google Scholar
  193. Turner PR, Westwood T, Regen CM and Steinhardt RA (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 355: 735–738.Google Scholar
  194. Turner PR, Fong P, Denetclaw WF and Steinhardt RA (1991) Increased calcium influx in dystrophic muscle. J Cell Biol 115: 1701–1712.Google Scholar
  195. Turner PR, Schultz R, Ganguly B and Steinhardt RA (1993) Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J Membr Biol 133: 243–251.Google Scholar
  196. Tutdibi O, Brinkmeier H, Rudel R and Fohr KJ (1999) Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers. J Physiol 515: 859–868.Google Scholar
  197. Vaghy PL, Fang J, Wu W and Vaghy LP (1998) Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 431: 125–127.Google Scholar
  198. Valentine BA, Winand NJ and Pradhan D (1992) Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy. Am J Med Genet 42: 352–356.Google Scholar
  199. Wakayama Y and Shibuya S (1990) Observation on the muscle plasma membrane-associated cytoskeletons of mdx mice by quick-freez, deep etch, rotary-shadow replica method. Acta Neuropathol 80: 618–623.Google Scholar
  200. Wakeford S, Watt DJ and Partridge TA (1991) X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14: 42–50.Google Scholar
  201. Wang N, Butler JP and Ingber DE (1993) Mechanotransduction across the cell surface and through the cytoskeleton. Science 260: 1124–1127.Google Scholar
  202. Webster C, Silberstein L, Hays AP and Blau HM (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell 52: 502–513.Google Scholar
  203. Weller B, Karpati G, Lehnert S and Carpenter S (1991a) Major alteration of the pathological phenotype in gamma irradiated mdx soleus muscles. J Neuropathol Exp Neurol 50: 419–431.Google Scholar
  204. Weller B, Massa R, Karpati G and Carpenter S (1991b) Glucocorticoids and immunosuppressants do not change the prevalence of necrosis and regeneration in mdx skeletal muscles. Muscle Nerve 14: 771–774.Google Scholar
  205. Winder SJ (1997) The membrane-cytoskeleton interface: the role of dystrophin and utrophin. J Muscle Res Cell Motil 18: 617–629.Google Scholar
  206. Winder SJ and Kendrick-Jones J (1995) Calcium/calmodulin-dependent regulation of the NH2 terminal F-actin binding domain of utrophin. FEBS Lett 357: 125–128.Google Scholar
  207. Winder SJ, Gibson TJ and Kendrick-Jones J (1995) Dystrophin and utrophin: the missing links! FEBS Lett 369: 27–33.Google Scholar
  208. Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AHM, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN and Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333: 466–469.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • J. M. Gillis
    • 1
  1. 1.Département de PhysiologieUniversité Catholique de Louvain, UCL 5540BruxellesBelgium

Personalised recommendations